US Deals Volume Almost Doubles in a Year

The first six months of 2014 proved to be the most active for US merger and acquisition (M&A) deals since the first half of 2007, according to The Mergermarket Group.

At US$694.6bn, US M&A deals were worth 98.3% more than H113 when they totaled US$350.2bn and increased by 30% from H213 (US$534.3bn), according to the ‘Mergermarket H1 2014 trend report’.

Among other key US findings from the report:

  • Q214 was valued at US$405.2bn, an increase of 135.6% on Q213’s value of US$172bn and making Q214 the highest valued quarter since Q207.
  • Compared to other world regions, the US experienced the largest increase in M&A from last year; its 44.2% share of the global market by deal value during H114 was up from 34.8% in H113.
  • Private equity (PE) buyout value during H114, at US$80.1bn reached the second most active half year post-crisis, despite no mega-valued buyouts. H113 surpassed current levels only as a result of two mega-buyouts worth US$ 47.5bn.

Globally there were a total of US$1,571.2bn M&A deals over the first six months of 2014, a 56.3% increase over H113. The pharmaceutical, medical and biotech sector contributed US$258.6bn, a year-on-year (YoY) increase of 225.7%.

The H1 total for Europe was US$453.6bn and for Asia US$286.7bn, representing YoY increases of 35.5% and 56.8% respectively.


Related reading